<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051075</url>
  </required_header>
  <id_info>
    <org_study_id>RMB 0443-13</org_study_id>
    <secondary_id>0443-13-RMB</secondary_id>
    <nct_id>NCT02051075</nct_id>
  </id_info>
  <brief_title>Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation</brief_title>
  <acronym>PXN</acronym>
  <official_title>A Randomized Controlled Trial to Compare Fertilizations With Immotile Sperm After Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immotile sperm is a rather frequent problem encountered in IVF patients. Treatment is usually
      based on inducing motility with pentoxyphylline (PXN) followed by ICSI. However,
      fertilization rate with this method is still lower compared with ICSI using motile sperm. One
      of the reasons for that is the immotile sperm inability to activate the oocyte Our research
      hypothesis is that better fertilization rate can be accomplished in these cases by combining
      PXN sperm activation with Ca ionophore oocyte activation.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    failure to recruit
  </why_stopped>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>One month post oocyte retrieval</time_frame>
    <description>Demonstration of fetal heart activity 1 month post oocyte retrieval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>One day post oocyte retrieval</time_frame>
    <description>Normal, 2 pronuclei, zygote one day post ICSI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>PXN only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sperm activation with PXN before ICSI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PXN activation and oocyte activation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sperm activation with PXN and oocyte activation</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PXN sperm treatment</intervention_name>
    <description>immotile sperm activation with PXN</description>
    <arm_group_label>PXN only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Sperm activation with PXN and oocyte activation</intervention_name>
    <arm_group_label>PXN activation and oocyte activation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women up to 35 years of age

          -  immotile sperm

          -  At least 6 mature eggs

        Exclusion Criteria:

          -  globozoospermia

          -  &quot;Freeze all&quot; cycles because of OHSS risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rambam medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2014</study_first_submitted>
  <study_first_submitted_qc>January 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Shahar Kol MD</investigator_full_name>
    <investigator_title>Durector, IVF Unit</investigator_title>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>ICSI</keyword>
  <keyword>Asthenospermia</keyword>
  <keyword>pentoxyphylline</keyword>
  <keyword>Spermatozoa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pentoxifylline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

